BOSTON LIFE SCIENCE VENTURE
Boston Life Science Venture Co. specializes in seed to late stage, expansion stage, and growth stage.
BOSTON LIFE SCIENCE VENTURE
Status:
Active
Similar Organizations
LYZZ Capital
LYZZ Capital is a venture capital firm specialized in seed, early, and expansion stage venture investments.
Reinforced Ventures
Reinforced Ventures focuses on helping founders with both capital and expertise at seed or pre-seed stages.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2008-07-09 | ConforMIS | Boston Life Science Venture investment in Series D - ConforMIS | 14.92 M USD |
| 2007-09-26 | GlobeImmune | Boston Life Science Venture investment in Series C - GlobeImmune | 41.2 M USD |
| 2007-08-09 | Nereus Pharmaceuticals | Boston Life Science Venture investment in Series D - Nereus Pharmaceuticals | 45 M USD |
| 2006-04-11 | Bayhill Therapeutics | Boston Life Science Venture investment in Venture Round - Bayhill Therapeutics | 15.8 M USD |
| 2005-05-04 | Bayhill Therapeutics | Boston Life Science Venture investment in Series B - Bayhill Therapeutics | 35.4 M USD |
More informations about "Boston Life Science Venture"
Boston Life Sciences Showcase
Creating quarterly business showcase events for Boston life sciences entrepreneurs, executives and investors. ... Building bridges between the Boston life sciences community and international venture capital and startup …See details»
Boston Life Science Venture - Crunchbase
Venture Capital Investors with Investments in Greater San Diego Area 1,971 Number of Organizations • $123.5B Total Funding Amount • 521 Number of Investors TrackSee details»
About - BioXchange
BioXchange is a premier life sciences networking organization founded by some of the most networked people in the Boston life sciences hub. ... he loves providing tailored banking and debt solutions to entrepreneurial companies …See details»
Boston Life Sciences Showcase - LinkedIn
Boston Life Sciences Showcase | 309 followers on LinkedIn. Quarterly Networking and Showcasing Events for Boston-based Life Sciences Entrepreneurs, Investors and Executives. | Boston New ...See details»
2025 Biomedical Pitch Competition Registration – Boston Capital ...
The Boston Capital Investment Club (BCIC) is a Massachusetts-registered non-profit organization serving nearly 10,000 professionals in finance, venture capital, and various technology …See details»
SV Health Investors - Crunchbase Investor Profile
SV Health Investors, formerly SV Life Sciences, is a leading healthcare and life sciences venture capital and growth equity firm. Their goal is to transform healthcare – one investment at a time – by supporting the entrepreneurs who …See details»
Boston Life Science Venture investment portfolio - PitchBook
Dec 29, 2009 Boston Life Science Venture General Information Company Description. Boston Life Science Venture was founded in 2003, with a capital of NT$2 billions. The investment …See details»
Fenwick Launches Boston Office with Leading Life Sciences
Apr 14, 2025 The firm has served as counsel to hundreds of clients in the Boston community, from venture capital firms like MRL Ventures to notable life sciences and technology leaders …See details»
Boston's life sciences industry looks to rebound in 2025
Jan 9, 2025 The latest economic development package Gov. Healey signed into law, which includes a $500 million investment in the life sciences industry, signals Massachusetts' …See details»
Navigating the Boston BioTech Startup Scene - Who to …
Nov 8, 2022 Harvard Biotech Club - a student organization on a mission to bridge the gap between industry and academia and provide the education, ... Boston Life Sciences Showcase - a collaboration between bioverse, ... 5AM …See details»
24Q3 Greater Boston Life Sciences Report - Colliers
Nov 25, 2024 Venture capital activity is perking up. Total availabilities reached a new record high in the third quarter. The 13.5 million SF is about 24.5% of all lab and GMP space across the …See details»
Top 35 Biotech Companies in Boston: From Biotech Startups to
Jan 6, 2025 17. Wave Life Sciences. Focus: Genetic Medicines Description: Wave Life Sciences develops precision medicines that address the genetic causes of diseases like Huntington’s …See details»
Orrick Expands Life Sciences & Tech Venture Capital Practice with ...
Life sciences and tech company advisors Mark Solakian and Jake Gatof join the firm as partners.; Leaders in the Boston venture capital ecosystem, Mark and Jake guide companies and their …See details»
How Massachusetts Built A Booming Biotech Ecosystem
The state also has 31 biotech and life sciences incubators. The Massachusetts Life Sciences Center (MLSC), an economic development and investment agency, has invested more than …See details»
Boston Scientific Ventures | Investor profile | Foundersuite
Life Sciences. Health & Wellness (LOHAS) Description. Boston Scientific Ventures is the venture capital arm of Boston Scientific. The company invests in and support innovative MedTech …See details»
Life Sciences: Southline to get a new tenant and a big addition
Mar 31, 2023 Then, this week, life sciences venture capital (VC) firm Portal Innovations announced that it will be moving next month into 22,000 square feet of space in the original …See details»
Boston Life Science Venture - Investments, Portfolio & Company …
Jul 9, 2008 Boston Life Science Venture 's most notable exits include ConforMIS, Nereus Pharmaceuticals, and GlobeImmune. Which industries has this organization had the most …See details»
Cooley Adds Key Emerging Companies and Venture Capital …
1 day ago Boston – May 7, 2025 ... “Boston is a critical tech, life sciences and venture market for us, and Laura will be a leader of our continued growth in the market.” ... and your access or …See details»
Bain Capital and Botanic Properties Acquire Greater Boston …
2 days ago Ventures > Life Sciences > Tech Opportunities > Crypto > Capital Solutions. ... BOSTON and NEW YORK – May 7, ... Bain Capital and Botanic formed GenesisM to offer life …See details»
Life Sciences Report | 2025 | Colliers
Mar 31, 2025 The long-term outlook for life sciences companies remains strong. ... overall venture capital funding was $5.6 billion higher last year than in 2023, making 2024 the fourth …See details»